Form 4 for CCCC C4 Therapeutics, Inc.
Accepted 2021-09-14 00:00:00 ET · period of report 2021-09-10 · accession 0001209191-21-055881 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-14 | 2021-09-10 | CCCC | Siegel Jolie | CLO | M - OptEx | $4.98 | +12.5K | 12.5K | New | +$62.3K |
| D | 2021-09-14 | 2021-09-10 | CCCC | Siegel Jolie | CLO | S - Sale+OE | $50.00 | -12.5K | 0 | -100% | -$625.0K |
| D | 2021-09-14 | 2021-09-10 | CCCC | Siegel Jolie | CLO | M - OptEx | $0.00 | -12.5K | 271.3K | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-10 | M | A | 12,500 | $4.98 | 12,500 | D | — | — | |
| 2 | Common | Common Stock | 2021-09-10 | S | D | 12,500 | $50.00 | 0 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2021-09-10 | M | D | 12,500 | $0.00 | 271,321 | D | $4.98 · — to 2030-07-02 | 12,500 Common Stock | (F2) 20% of this option vested and became exercisable on July 1, 2021, with the remainder vesting in 16 equal quarterly installments thereafter. |